Cancel anytime
SWK Holdings Corp (SWKH)SWKH
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: SWKH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Profit: -13.73% | Upturn Advisory Performance 2 | Avg. Invested days: 50 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Profit: -13.73% | Avg. Invested days: 50 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 209.53M USD |
Price to earnings Ratio 18.03 | 1Y Target Price 24 |
Dividends yield (FY) - | Basic EPS (TTM) 0.94 |
Volume (30-day avg) 10206 | Beta 0.36 |
52 Weeks Range 15.52 - 18.75 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 209.53M USD | Price to earnings Ratio 18.03 | 1Y Target Price 24 |
Dividends yield (FY) - | Basic EPS (TTM) 0.94 | Volume (30-day avg) 10206 | Beta 0.36 |
52 Weeks Range 15.52 - 18.75 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 45.95% | Operating Margin (TTM) 39.13% |
Management Effectiveness
Return on Assets (TTM) 3.87% | Return on Equity (TTM) 4.25% |
Valuation
Trailing PE 18.03 | Forward PE - |
Enterprise Value 236298542 | Price to Sales(TTM) 8.13 |
Enterprise Value to Revenue 5.7 | Enterprise Value to EBITDA 14.04 |
Shares Outstanding 12361800 | Shares Floating 1583677 |
Percent Insiders 1.2 | Percent Institutions 94.21 |
Trailing PE 18.03 | Forward PE - | Enterprise Value 236298542 | Price to Sales(TTM) 8.13 |
Enterprise Value to Revenue 5.7 | Enterprise Value to EBITDA 14.04 | Shares Outstanding 12361800 | Shares Floating 1583677 |
Percent Insiders 1.2 | Percent Institutions 94.21 |
Analyst Ratings
Rating 4 | Target Price 24 | Buy 1 |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating 4 | Target Price 24 | Buy 1 | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
SWK Holdings Corp.: A Comprehensive Overview
Company Profile
Detailed history and background: SWK Holdings Corp. (NASDAQ: SWKH) is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated in 2021. These companies are created solely for the purpose of acquiring another company. SWKH has not yet completed its initial business combination with a target company.
Core business areas: SWKH focuses on identifying and acquiring businesses within the consumer, technology, media, and telecommunications sectors. The company looks for businesses with strong growth potential and experienced management teams.
Leadership team and corporate structure: The company's leadership team consists of experienced professionals with backgrounds in investment banking, private equity, and operations. The current CEO is Mr. Marc Leder. SWKH operates with a lean corporate structure, streamlining decision-making and maximizing efficiency.
Top Products and Market Share:
Top products and offerings: As a SPAC, SWKH does not currently have any products or services. Once the company acquires a target company, its product portfolio will be determined by the acquired business.
Market share: N/A, as the company has not yet acquired a target company.
Product performance and market reception: N/A
Total Addressable Market:
Market size: The global market for mergers and acquisitions is estimated to be over $3 trillion annually. The specific market size for SWKH's target industries (consumer, technology, media, and telecommunications) is difficult to quantify, as it will depend on the specific company they choose to acquire.
Financial Performance:
Financial statements: SWKH has not yet generated any revenue or profits. As of their latest quarterly report, the company had a cash balance of approximately $229 million.
Year-over-year financial performance: N/A, as the company has not yet been in operation for a full year.
Cash flow and balance sheet health: The company's current financial health is strong, with a significant cash balance and no debt. However, this will change once they complete their acquisition.
Dividends and Shareholder Returns:
Dividend history: SWKH does not currently pay dividends.
Shareholder returns: Since their IPO in October 2021, SWKH's stock price has declined by approximately 50%.
Growth Trajectory:
Historical growth: N/A, as the company has not yet completed an acquisition.
Future growth projections: The company's future growth will depend on the performance of the business they acquire.
Product launches and strategic initiatives: N/A
Market Dynamics:
Industry overview: The SPAC industry has grown significantly in recent years. However, the performance of SPACs after completing their acquisitions has been mixed.
SWK's position and adaptability: SWKH is well-positioned to capitalize on the growth of the SPAC industry. Their experienced management team and flexible acquisition strategy should allow them to adapt to changing market conditions.
Competitors:
Key competitors: Other SPACs in the market, such as Churchill Capital Corp IV (CCIV) and Gores Group (GRSV).
Market share: N/A, as SWKH has not yet completed an acquisition.
Competitive advantages and disadvantages:
- Advantages: Experienced management team, flexible acquisition strategy, strong financial resources.
- Disadvantages: Unproven track record, exposure to market volatility.
Potential Challenges and Opportunities:
Key challenges: Difficulty identifying and acquiring a suitable target company, integrating the acquired business successfully, managing market volatility.
Potential opportunities: Growth of the SPAC industry, access to new markets and technologies, increase in shareholder value.
Recent Acquisitions (last 3 years):
N/A, as the company has not yet completed an acquisition.
AI-Based Fundamental Rating:
Rating: 6/10
Justification: SWKH has a strong financial profile and an experienced management team. However, the company is still in its early stages and has not yet completed an acquisition. The future success of the company will depend on their ability to identify and acquire a suitable target company and integrate it successfully.
Sources and Disclaimers:
Sources:
- SWK Holdings Corp. website
- SEC filings
- Financial news sources
Disclaimer: The information provided in this overview is for general knowledge and informational purposes only, and does not constitute financial advice. It is essential to conduct your own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SWK Holdings Corp
Exchange | NASDAQ | Headquaters | Dallas, TX, United States |
IPO Launch date | 1999-09-22 | CEO & President | Mr. Jody. D Staggs |
Sector | Financial Services | Website | https://www.swkhold.com |
Industry | Asset Management | Full time employees | 22 |
Headquaters | Dallas, TX, United States | ||
CEO & President | Mr. Jody. D Staggs | ||
Website | https://www.swkhold.com | ||
Website | https://www.swkhold.com | ||
Full time employees | 22 |
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.